BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 17575528)

  • 1. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid secretion and the H,K ATPase of stomach.
    Prinz C; Kajimura M; Scott D; Helander H; Shin J; Besancon M; Bamberg K; Hersey S; Sachs G
    Yale J Biol Med; 1992; 65(6):577-96. PubMed ID: 1341065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric acid secretion: activation and inhibition.
    Sachs G; Prinz C; Loo D; Bamberg K; Besancon M; Shin JM
    Yale J Biol Med; 1994; 67(3-4):81-95. PubMed ID: 7502535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor and ion binding sites on the gastric H,K-ATPase.
    Munson K; Garcia R; Sachs G
    Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
    Shin JM; Cho YM; Sachs G
    J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gastric H+,K+-ATPase: the site of action of omeprazole.
    Sachs G; Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():3-11. PubMed ID: 2557669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain.
    Vagin O; Denevich S; Munson K; Sachs G
    Biochemistry; 2002 Oct; 41(42):12755-62. PubMed ID: 12379118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological transformations associated with parietal cell stimulation: critical steps in the activation cascade.
    Agnew BJ; Duman JG; Watson CL; Coling DE; Forte JG
    J Cell Sci; 1999 Aug; 112 ( Pt 16)():2639-46. PubMed ID: 10413672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton-Potassium (H(+)/K(+)) ATPases: Properties and Roles in Health and Diseases.
    Sakai H; Fujii T; Takeguchi N
    Met Ions Life Sci; 2016; 16():459-83. PubMed ID: 26860309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
    Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological basis of omeprazole therapy.
    Sachs G; Wallmark B
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the gastric H,K ATPase for ion pathways and inhibitor binding sites.
    Munson K; Law RJ; Sachs G
    Biochemistry; 2007 May; 46(18):5398-417. PubMed ID: 17425287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Physiology of the Gastric Parietal Cell.
    Engevik AC; Kaji I; Goldenring JR
    Physiol Rev; 2020 Apr; 100(2):573-602. PubMed ID: 31670611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntaxin 3 is required for cAMP-induced acid secretion: streptolysin O-permeabilized gastric gland model.
    Ammar DA; Zhou R; Forte JG; Yao X
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G23-33. PubMed ID: 11751154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
    Zhang Q; Huang N; Wang J; Luo H; He H; Ding M; Deng WQ; Zou K
    Fitoterapia; 2013 Sep; 89():210-7. PubMed ID: 23742858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent trafficking of the KCNQ1 K+ channel and H+-K+-ATPase in gastric parietal cells from mice.
    Nguyen N; Kozer-Gorevich N; Gliddon BL; Smolka AJ; Clayton AH; Gleeson PA; van Driel IR
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G157-66. PubMed ID: 23154976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.